hello world
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.
Stocks in play: Medicenna Therapeutics Corp.
Today reported financial results and corporate highlights for the fiscal quarter ended September 30, 2024. The Company reported a net loss of $4.2 million ($0.05 per share) compared to a net loss of $3.7 million ($0.05 per share) for the three months ended September 30, 2023. Medicenna Therapeutics Corp. shares T.MDNA are trading down $0.07 at $1.63.
